Suanfarma Suanfarma

X

Find Tc-99M Sulfur Colloid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Tc-99M Sulfur Colloid
Also known as: Technetium tc-99m sulfur colloid, Tc99m-sulfur colloid, Technetium tc 99m tsc, 99mtc-labeled sulfur colloid, Technetium 99m sulfur colloid, 556q0p6pb1
Molecular Formula
S8Tc
Molecular Weight
355.4  g/mol
InChI Key
FJTPHHNWVXNMEK-IEOVAKBOSA-N
FDA UNII
556Q0P6PB1

A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.
Technetium tc-99m sulfur colloid is a Radioactive Diagnostic Agent. The mechanism of action of technetium tc-99m sulfur colloid is as a Radiopharmaceutical Activity.
1 2D Structure

Tc-99M Sulfur Colloid

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
octathiocane;technetium-99
2.1.2 InChI
InChI=1S/S8.Tc/c1-2-4-6-8-7-5-3-1;/i;1+1
2.1.3 InChI Key
FJTPHHNWVXNMEK-IEOVAKBOSA-N
2.1.4 Canonical SMILES
S1SSSSSSS1.[Tc]
2.1.5 Isomeric SMILES
S1SSSSSSS1.[99Tc]
2.2 Other Identifiers
2.2.1 UNII
556Q0P6PB1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Colloid, Tc-99m Sulfur

2. Colloid, Technetium Sulfur

3. Lymphoszint

4. Tc 99m Sulfur Colloid

5. Tc-99m Sulfur Colloid

6. Technetium Sulfur Colloid

2.3.2 Depositor-Supplied Synonyms

1. Technetium Tc-99m Sulfur Colloid

2. Tc99m-sulfur Colloid

3. Technetium Tc 99m Tsc

4. 99mtc-labeled Sulfur Colloid

5. Technetium 99m Sulfur Colloid

6. 556q0p6pb1

7. Technetium (99mtc) Sulfur Colloid

8. Db09397

9. Technetium Tc 99m Sulfur Colloid [usan]

10. Technetium Tc 99m Sulfur Colloid [who-dd]

11. Q27261285

12. Technetium Tc 99m Sulfur Colloid [usp Impurity]

13. Technetium Tc-99m Sulfur Colloid [orange Book]

2.4 Create Date
2014-08-25
3 Chemical and Physical Properties
Molecular Weight 355.4 g/mol
Molecular Formula S8Tc
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count0
Exact Mass354.682819 g/mol
Monoisotopic Mass354.682819 g/mol
Topological Polar Surface Area202 Ų
Heavy Atom Count9
Formal Charge0
Complexity24
Isotope Atom Count1
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Technetium 99m sulfur colloid is indicated as a diagnostic agent in adults for the following tests: localization of lymph nodes draining a primary tumor in patients with breast cancer or malignant melanoma; and evaluation of peritoneo-venous (LeVeen) shunt patency. It is indicated in both adult and pediatric patients for: imaging areas of functioning reticuloendothelial cells in the liver, spleen and bone marrow; and studies of esophageal transit and gastroesophageal reflux, and detection of pulmonary aspiration of gastric contents.


FDA Label


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Radiopharmaceuticals

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
TECHNETIUM TC-99M SULFUR COLLOID
5.2.2 FDA UNII
556Q0P6PB1
5.2.3 Pharmacological Classes
Mechanisms of Action [MoA] - Radiopharmaceutical Activity
5.3 ATC Code

V - Various

V09 - Diagnostic radiopharmaceuticals

V09D - Hepatic and reticulo endothelial system

V09DB - Technetium (99mtc), particles and colloids

V09DB05 - Technetium (99mTc) sulfur colloid


5.4 Absorption, Distribution and Excretion

Absorption

When administered subcutaneously, Technetium Tc 99m Sulfur Colloid enters the lymphatic capillaries and is transported with lymph to lymph nodes where it can be used to detect drainage of primary tumours. When administered by intraperitoneal injection, Technetium Tc 99m Sulfur Colloid mixes with the peritoneal fluid where the rate of clearance from the cavity allows assessment of shunt patency. When administered by intravenous injection, Technetium Tc 99m Sulfur Colloid is taken up by the reticuloendothelial system (RES), allowing RES rich structures to be imaged. Uptake of the radioactive colloid by organs of the RES is dependent upon both their relative blood flow rates and the functional capacity of the phagocytic cells. When administered orally, Technetium Tc 99m sulfur colloid can be used in esophageal transit studies, gastroesophageal reflux scintigraphy, and for the detection of pulmonary aspiration of gastric contents. This is possible as the active substance is not absorbed from the GI tract.


Route of Elimination

Following oral ingestion, elimination is primarily through the feces.


Volume of Distribution

Following oral ingestion, Technetium Tc 99m Sulfur Colloid is distributed primarily through the gastrointestinal tract.


5.5 Metabolism/Metabolites

In the average patient 80 to 90% of the injected collodial particles are phagocytized by the Kupffer cells of the liver, 5 to 10% by the spleen and the balance by the bone marrow.


5.6 Biological Half-Life

Technetium Tc 99m decays by isomeric transition with a physical half-life of 6.02 hours. Following intravenous administration, Technetium Tc 99m Sulfur Colloid Injection is rapidly cleared from the blood by the reticuloendothelial system with a nominal half-life of approximately 2 1/2 minutes.


5.7 Mechanism of Action

Following injection or oral administration, single photon emission computer tomography (SPECT) imaging is performed using a gamma camera to detect technetium-99m decay. This is possible as Technetium-99m decays by isomeric transition to technetium-99 through the release of a gamma ray.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY